Pathios Therapeutics Raises $25M in First Close of Series B Financing to Advance First-in-Class Immunotherapy Approach into Clinic

/PRNewswire/ -- Pathios Therapeutics Limited ("Pathios"), a biotech company focused on the development of first-in-class therapies for cancer, today announced...

Related Keywords

United Kingdom ,United States ,American ,Stuart Hughes ,Tim Brons ,Tom Mccarthy ,Leadership Team To ,Innovation Centre On Milton Park ,Prnewswire Pathios Therapeutics Limited ,American Association For Cancer Research ,Bristol Myers Squibb ,Stage Company ,Fundraising Includes New Strategic Investment ,Continued Support ,Existing Investors ,Advance Lead Candidate ,Expand Leadership Team ,Pathio Transition ,Therapeutics Limited ,Brandon Capital ,American Association ,Cancer Research ,Annual Meeting ,Pathios Therapeutics ,Canaan Partners ,Bristol Myers ,Innovation Centre ,Milton Park ,Grey Wolf Therapeutics ,Executive Chair ,Chief Executive ,Chief Scientific ,Strategic Partners ,